Clinical trial
Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis…
NCT05540717 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT05540717 |
|---|---|
| Title | Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen |
| Official title | A Randomised, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen Exposure |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seasonal Allergic Rhinitis, Rhinoconjunctivitis |
| Intervention type | Biological |
| Interventions | PQ Grass, Placebo |
| Enrollment | 555 |
| Start date | Oct 11, 2022 |
| Primary completion | Nov 1, 2023 |
| Completion | Nov 1, 2023 |
| First posted | Sep 15, 2022 |
| Last update posted | Apr 2, 2025 |
| Countries | Austria, Czechia, Germany, Hungary, Poland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: